½üÈÕ£¬Ð±¦GGҽѧԺ¶Ïö¸±½ÌÊÚÔÚÃÀ¹ú»¯Ñ§»áÆì½¢ÆÚ¿¯ACS Cent Sci(Ó°ÏìÒò×Ó18.2)ÉÏ°ä·¢ÌâΪ¡°Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy¡±µÄ×ÛÊöÂÛÎÄ¡£
б¦GGҽѧԺ¶Ïö¸±½ÌÊÚºÍ˶ʿÉúÏÄÊæΪ¸ÃÂÛÎĵĹ²Í¬µÚÒ»×÷Õߣ¬Ð±¦GGҽѧԺ¶Ïö¸±½ÌÊÚºÍÉϺ£½»´óҽѧԺ·½³¬½ÌÊÚ¹²Í¬Í¨Ñ¶×÷Õß¡£
°©Ö¢ÃâÒßÁÆ·¨ÊÇÒ»ÖÖͨ¹ý¼¤»îËÞÖ÷ÃâÒß·´Ó³À´ÒÖÔìÖ×Áö³É³¤ºÍתÒƵÄÖ×ÁöÒ½ÖÎз¶Ê½£¬½üÄêÀ´ÒÑ»ñµÃÍ»ÆÆÐÔ½øÕ¹¡£È»¶ø£¬ÔÚÏÖʵÁÙ´²ÀûÓùý³ÌÖÐÈÔÃæ¶Ô»¼ÕßÏìÓ¦Âʵͣ¬¶¾¸±×÷ÓôóµÈÌôÕ½¡£×êÑз¢ÏÖ£¬¹ý¶ÈÔöÖ³µÄÖ×Áöϸ°û»á¼Ó¾çÖ×ÁöÓªÑøÎïÖʺÍÑõÆøµÄ¿÷Ë𣬵¼Ö²úÉúÒÔËáÐÔ¡¢È±Ñõ¡¢ÓªÑøØÑ·¦ºÍÃâÒßÒÖÔìÐÔ´úл²úÆ·¶Ñ»ýΪÖØÒªÌصãµÄÖ×Áö´úл΢»·¾³µÄ±ä¶¯¡£ÕâЩÒì³£µÄÖ×Áö´úл΢»·¾³ÏÞ¶ÈÁËÖ×Áö½þÈóÃâÒßϸ°ûµÄÖ°ÄÜ£¬ÍƽøÁËÖ×ÁöÃâÒßÌÓÒÝ£¬Ó°ÏìÁÙ´²ÃâÒßÒ½ÖεÄÔ¤ºó¡£Òò¶ø£¬°ÐÏòµ÷¿ØÖ×Áö´úлÓÐÍû¡°³ÁÕñ¡±¿¹Ö×ÁöÃâÒß·´Ó³£¬¼ÓÇ¿Ö×ÁöÃâÒßÒ½ÖÎ×÷Óá£Îª¿Ë·þÖ×Áö´úл΢»·¾³Æ¥µÐÖ×ÁöÃâÒß·´Ó³²úÉúµÄÒÖÔì×÷Ó㬽üÄêÀ´×êÑÐÈËÔ±¿ª·¢ÁËһϵÁпɡ°¸Äд¡±Ö×Áö´úлµÄÄÉÃ×Ò©ÎÒÑ·¢Õ¹³ÉΪÖ×ÁöÃâÒßÒ½ÖεÄÐÂÕ½Êõ¡£
½üÈÕ£¬Ð±¦GGҽѧԺ¶Ïö¸±½ÌÊÚ½áºÏÉϺ£½»´óҽѧԺ·½³¬½ÌÊÚÍŶӶԸÃÁìÓòµÄ×êÑнøÕ¹½øÐÐÁËϵͳÐÔ×ܽᡣ×÷ÕßÊ×ÏÈÊáÀíÁËÖ×Áö´úл¹ýÎʽáºÏÖ×ÁöÃâÒßÒ½ÖεÄÁÙ´²ÊÔÑé½øÕ¹£¬Ëæºó³Áµã½éÉÜÁËÖ×Áö´úл¡°¸Äд¡±ÐÍÄÉÃ×Ò©ÎïµÄÉè¼Æ˼·ÒÔ¼°ÕâЩÄÉÃ×Ò©Îïͨ¹ýµ÷¿ØÖ×ÁöÆÏÌÑÌÇ´úл¡¢°±»ùËá´úл¡¢Ö¬ÖÊ´úлºÍºËÜÕËá´úлÒÔ¼ÓÇ¿¹ÌÓкÍÊÊÓ¦ÐÔ¿¹Ö×ÁöÃâÒß·´Ó³µÄ×÷ÓúͻúÔ죨ͼ1£©¡£×îºó£¬×÷Õß»¹»áÉÌÁ˸ÃÁìÓòÃæ¶ÔµÄÌôÕ½ºÍ½«À´µÄ×êÑз½Ïò£¬Ô̺¬ÈôºÎ´´ÔìÄÉÃ×Ò©ÎïÒÔ¿Ë·þÖ×Áö´úл´ú³¥ÐÔͨ·¡¢ÈôºÎ¾«×¼°ÐÏòµ÷¿ØÖ×Áöϸ°û´úл¶ø²»Ó°ÏìÃâÒßϸ°ûµÄÕý³£Ö°Äܵȡ£
ͼ1.Ö×Áö´úл¡°¸Äд¡±ÐÍÄÉÃ×Ò©ÎïÓÃÓÚ°©Ö¢ÃâÒßÒ½ÖΡ£
ÂÛÎÄÁ´½Ó£ºhttps://doi.org/10.1021/acscentsci.3c00702
¶Ïö£¬¸±½ÌÊÚ£¬ÉϺ£Êк£±í¸ßµµ´ÎÈ˲š£2019Äê6Ô±ÏÒµÓÚÉϺ£½»Í¨´óѧҽѧԺҩѧרҵ£¬»ñ²©Ê¿Ñ§Î»£¨µ¼Ê¦£º·½³¬½ÌÊÚ£©¡£2019Äê8ÔÂÖÁ2021Äê8ÔÂÔÚмÓƹúÁ¢´óѧ£¨QS 2019ÊÀ½çÅÅÃû11£©´ÓÊ¿Æѧ×êÑУ¬ÈÎResearch Fellow£¨ºÏ×÷µ¼Ê¦£ºProf Yao Shao Qin£©¡£2022Äê1Ô²ÎÓëб¦GGҽѧԺ£¬×êÑз½ÏòΪ»ùÓÚÄÉÃ×¼¼ÊõµÄÖ×Áö°ÐÏò½áºÏÒ½ÖÎÕ½Êõ×êÑС£Ö÷³Ö¹ú¶ÈÌìÈ»¿Æѧ»ù½ðÇàÄê»ù½ð£¬ÉϺ£ÊпÆί¹ú¼ÊºÏ×÷ÏîÄ¿£¬ÉϺ£ÊпÆίÑï·«´òËãµÈ¿ÎÌ⡣ĿǰÒÔµÚÒ»×÷Õߣ¨º¬¹²Ò»£©»òͨѶ×÷Õߣ¨º¬¹²Í¨Ñ¶£©ÔÚACS Cent. Sci.£¬Angew. Chem. Int. Ed. Engl.£¬Adv.Funct. Mater.£¬Nano Lett.£¬Biomaterials£¬Chem. Sci.£¬ACS Sens.µÈ¹ú¼ÊÆÚ¿¯ÉÏ°ä·¢ÂÛÎÄ7ƪ£¬ÀۼƲμӰ䷢SCIÂÛÎÄ20Óàƪ£¬µ£ÈÎPharmaceutics£¨IF5.4£©ÔÓÖ¾¿Í×ù±à×ë¡£
